- Home
- MRVI vs GHI Comparison
MRVI vs GHI Comparison
Compare MRVI & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- GHI
- Stock Information
- Founded
- MRVI 2014
- GHI 1998
- Country
- MRVI United States
- GHI United States
- Employees
- MRVI N/A
- GHI N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- MRVI Health Care
- GHI Finance
- Exchange
- MRVI Nasdaq
- GHI Nasdaq
- Market Cap
- MRVI 347.5M
- GHI 285.3M
- IPO Year
- MRVI 2020
- GHI N/A
- Fundamental
- Price
- MRVI $2.16
- GHI $12.21
- Analyst Decision
- MRVI Hold
- GHI Strong Buy
- Analyst Count
- MRVI 10
- GHI 3
- Target Price
- MRVI $7.59
- GHI $16.50
- AVG Volume (30 Days)
- MRVI 3.8M
- GHI 41.5K
- Earning Date
- MRVI 05-07-2025
- GHI 05-07-2025
- Dividend Yield
- MRVI N/A
- GHI 12.00%
- EPS Growth
- MRVI N/A
- GHI N/A
- EPS
- MRVI N/A
- GHI 0.76
- Revenue
- MRVI $259,185,000.00
- GHI $32,275,700.00
- Revenue This Year
- MRVI N/A
- GHI $224.89
- Revenue Next Year
- MRVI $14.59
- GHI N/A
- P/E Ratio
- MRVI N/A
- GHI $16.22
- Revenue Growth
- MRVI N/A
- GHI N/A
- 52 Week Low
- MRVI $2.07
- GHI $10.12
- 52 Week High
- MRVI $11.56
- GHI $16.25
- Technical
- Relative Strength Index (RSI)
- MRVI 28.06
- GHI 39.72
- Support Level
- MRVI $2.07
- GHI $12.44
- Resistance Level
- MRVI $2.43
- GHI $13.10
- Average True Range (ATR)
- MRVI 0.20
- GHI 0.32
- MACD
- MRVI 0.05
- GHI -0.10
- Stochastic Oscillator
- MRVI 14.06
- GHI 11.23
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.